Get started
Author

Apoorva Jagannath Nalawade

Observed names: Apoorva Nalawade, Nalawade, Apoorva
Observed institution: DY Patil Deemed to be University
ORCID: 0000-0002-3681-2612
Observed ORCID: 0000-0002-3681-2612
OpenAlex ID: A5020360221
Drug repurposing: re-inventing therapies for cancer without re-entering the development pipeline—a review
2022 · Shafina Siddiqui, Ankita Jaywant Deshmukh, et al. · Journal of the Egyptian National Cancer Institute · 44
PDF
Therapeutic potential of autophagy activators and inhibitors in lung and breast cancer- a review
2022 · Priyanka Mudaliar, Apoorva Nalawade, et al. · Molecular Biology Reports · 11
Anti-Cancer Phytopharmaceuticals
2022 · Priyanka Mudaliar, Apoorva Jagannath Nalawade, et al. · CRC Press eBooks
Identification of a Potent Autophagy Inhibitor in Lung and Breast Cancer
2021 · Mudaliar, Priyanka, Nalawade, Apoorva, et al. · Journal of Advanced Scientific Research
PDF
Works count: 4
Citation count: 55
H-index: 2
I10-index: 2
Year
Topic
Type